APA (7th ed.) Citation

YI, E., HR, G., AM, E. K., RF, G., HH, G., KM, Y., & HI, E. (2023). New quinazolinone-based derivatives as DHFR/EGFR-TK inhibitors: Synthesis, molecular modeling simulations, and anticancer activity. Archiv der Pharmazie, 356(1), e2200417. https://doi.org/10.1002/ardp.202200417

Chicago Style (17th ed.) Citation

YI, El-Gazzar, Ghaiad HR, El Kerdawy AM, George RF, Georgey HH, Youssef KM, and El-Subbagh HI. "New Quinazolinone-based Derivatives as DHFR/EGFR-TK Inhibitors: Synthesis, Molecular Modeling Simulations, and Anticancer Activity." Archiv Der Pharmazie 356, no. 1 (2023): e2200417. https://doi.org/10.1002/ardp.202200417.

MLA (9th ed.) Citation

YI, El-Gazzar, et al. "New Quinazolinone-based Derivatives as DHFR/EGFR-TK Inhibitors: Synthesis, Molecular Modeling Simulations, and Anticancer Activity." Archiv Der Pharmazie, vol. 356, no. 1, 2023, p. e2200417, https://doi.org/10.1002/ardp.202200417.